Korea recalls Sanofi Aventis' enoxaparin after OSCS contamination

Published: 2008-06-18 06:54:00

Updated: 2008-06-18 06:54:00

The Korea Food and Drug Administration has recently recalled one batch of the anticoagulant medicine Clexane (enoxaparin) which has been found to contain the contaminant over-sulphated chondroitin sulphate (OSCS).

The KFDA has been informed by the supplier of Clexane, Sanofi-Aventis Korea, th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK